Embed Size (px)
Citation preview
Concept Innovate presents:
ResveraTech
Chiao Chang
Prateek Diwan
Lucas C Rodriguez
Chronic Pain
Man On Fire:
• 25% of Americans suffer from
chronic pain
• Nearly 50% do not get effective
relief from current therapies
• Post surgical pain often clear
culprits
• In many common conditions
such as diabetic neuropathy, no
clear source of pain is found.
• The annual cost of chronic pain
is as high as $635 billion a year,
which is more than the yearly
costs for cancer, heart disease
and diabetes.
Innovation of tomorrows pain relief solutions
ResveraTech
Amare Stoudemire…
Why are you in a tub of wine???
• All natural (homeopathic)
• Found in wine, and dark
chocolate
• Potential usage:
• Heart Disease
• Cancer
• Metabolism
• Lifespan
• Pain relief
Resveratrol
Types of pain…
How is it currently treated???
What can be done???
Types of Pain
Acute Versus Chronic
Types of Pain
Biochemistry of Pain
Pain
Activator
Pain
Activator
Middle
-Men
Middle
-Men
Complex
Ribo
Efficacy
• OTC market as of 2013
~ $6Billion
• Internal Analgesic ~ 60%
• External Analgesic ~ 15%
• GIA estimates $34.6Billion in
analgesic market by 2015.
Market
Platform Technology
ResveraDerm
Creme
Pain Relief
Patch
Post-Surgical Pain Relief
Bandage
Pain Relief
Sutures
ResveraDerm Clinical Feasibility Study
Customer Acquisition and Backing
• Physical Therapists
• Elderly post-surgery patients
• Orthopedics
• Sports injury
• Chiropractors
• Homeopathic
• Medical spas and Compounding Pharmacists
• Massage
• Homeopathic
• Western Medicine
• Pain Relief Centers
• Desperate for pain relief
Marketing Plan
• Finish development of platform
• CMO manufacture agreement
• Data acquisition for downstream (IP protection)
• Website Design
• Clinical feasibility
• Large retail
Sales
• Website
• Clinic / Retail
• Distributer
Strategy
Strategy
ResveraTech
• BASF is an international
chemical manufacturer
• Agreement in place:
ResveraDerm development
R&D Manufacturer
• Manufacture product for :
• Fee for service
• Royalty
• Save startup capital
Contract Manufacture
Timeline
2011 2012 2013 2014 2015 2016 2017 2018
Hard Launch Patch, Bandage, Sutures
Phase III Begin (Commercialization, Angel/VC Funding)
Phase II Complete (Patch, Bandage, and Sutures Ready for Launch)
Break Even
Phase II Approval (Development of Downstream Products)
Hard Launch ResveraDerm (Large Retail)
Downstream Product IP Acquired
Phase I End
Soft Launch ResveraDerm (Clinical Feasibility Study)
SBIR/STTR Phase I Approval
Submission of SBIR/STTR
Draft of SBIR/STTR
Business Planning Begin
Publication III
Publication II
Publication I
• Phase I:
• Feasibility
• Clinical Study
• 6 months : $150k
• Hard Launch ResveraDerm
• Phase II:
• Downstream Product Development
• 2 years : $750k
• Phase III
(Commercialization)
• Angel/VC:
• Strong track via SBIR
• Manufacturer contract
• Ready for sales
$0
$500,000
$1,000,000
$1,500,000
$2,000,000
$2,500,000
$3,000,000
$3,500,000
8000 58,000 118,000 178,250 239,750 301,750 364,750
Units Sold
Revenue vs. Unit Sales
Sales Total Costs
Fixed Costs: $626,820
Variable Cost per Unit: $3
Unit Price: $7.20
Unit Increments: 10,000
BREAK-EVEN POINT: 149,243
Projections
• Fixed and variable costs analyzed
• Conservative Assumptions
• low price point
• two marketing channels
• Concentrate efforts on TX, NM, AR, LA
• Market penetration based on Lidoderm
1999
• Manufacturing keeps up with sales
$0.10 $2.00$5.00
$10.00
$50.00
$100.00
$0.0
$10.0
$20.0
$30.0
$40.0
$50.0
$60.0
$70.0
$80.0
$90.0
$100.0
2014 2015 2016 2017 2018 2019 2020
Sales in Millions
Revenue Projections
Financials
TOP DOWN
Year 0 Year 1 Year 2 Year 3 Year 4 Year 5
Market $500,000,000.00 $500,000,000.00 $500,000,000.00 $500,000,000.00 $500,000,000.00 $500,000,000.00
Penetration 0 0.1% 0.2% 0.4% 0.8% 1.6%
Rev $- $500,000.00 $1,000,000.00 $2,000,000.00 $4,000,000.00 $8,000,000.00
Costs $- $650,000.00 $767,000.00 $905,060.00 $1,067,970.80 $1,260,205.54
Profit $- $(150,000.00) $233,000.00 $1,094,940.00 $2,932,029.20 $6,739,794.46
BOTTOM UP
Year 0 Year 1 Year 2 Year 3 Year 4 Year 5
Units 0 50000.00 87500.00 153125.00 267968.75 468945.31
Locations
(at 2:1 C:R) 0 125.00 218.75 382.81 669.92 1172.36
Sales Rev 0 500000.00 875000.00 1531250.00 2679687.50 4689453.13
Costs
$
- $650,000.00 $767,000.00 $905,060.00 $1,067,970.80 $1,260,205.54
Profit
$
- $(150,000.00) $108,000.00 $626,190.00 $1,611,716.70 $3,429,247.58
Year 0 Year 1 Year 2 Year 3 Year 4 Year 5
$(150,000) $(500,000.00)
$500,000.00
$1,500,000.00
$2,500,000.00
$3,500,000.00
$4,500,000.00
$5,500,000.00
$6,500,000.00
$7,500,000.00
Financials
(150,000)
$(500,000.00)
$500,000.00
$1,500,000.00
$2,500,000.00
$3,500,000.00
$4,500,000.00
$5,500,000.00
$6,500,000.00
$7,500,000.00
Sales in Millions
Concept Innovate
• Well-Educated
• R&D Experience
• Marketing
• Sales
• Motivated
• Adaptable
• Strong Strategy
• Mentor Backing
Team
Madison PedigoJackie Kimzey
Greg Dussor Ted Price
Inventors
Mentors
• All-natural, homeopathic substance
• Low cost
• Available
• No side effects
• Proven Effectiveness
• Multiple Usages (Platform Technology)
In Summary…
